Efficacy and Drug Resistance Analysis of ALK Inhibitors in Combination with Stereotactic Body Radiation Therapy for Treating Lung Squamous Carcinoma Patient Harboring EML4-ALK Rearrangement

EML4-ALK rearrangement is common in lung adenocarcinoma. The ALK inhibitors remarkably inhibit lung adenocarcinoma and reveal long-term beneficial effects in several patients. Advanced genetic testing technology reveals that EML4-ALK rearrangement has been observed in patients with lung squamous cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Long, Mao, Mian, Wu, Lei, Chen, Taiyu, Lyu, Jiahua, Wang, Qifeng, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652916/
https://www.ncbi.nlm.nih.gov/pubmed/34887666
http://dx.doi.org/10.2147/OTT.S335736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652916/
https://www.ncbi.nlm.nih.gov/pubmed/34887666
http://dx.doi.org/10.2147/OTT.S335736

Ejemplares similares